IVF results in patients with very low serum AMH are significantly affected by chronological age
- 18 February 2016
- journal article
- assisted reproduction-technologies
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 33 (5) , 603-609
Abstract
Purpose The aims of this study were to assess the outcome of in vitro fertilization (IVF) in women with very low circulating anti-müllerian hormone (AMH) and to investigate factors affecting their probability of pregnancy. Methods The outcome of 448 IVF cycles in 361 women with circulating AMH p = 0.001). Differently, comparable IVF results were observed stratifying patients for AMH levels in the range 0.14–0.49 ng/ml. Multivariable logistic regression analysis confirmed that the probability of pregnancy was significantly affected by age, but not by small differences in AMH level. Conclusions Women with very low (<0.5 ng/ml) AMH levels undergoing IVF still have reasonable chances of achieving a pregnancy, but their prognosis is significantly affected by chronological age. Very low AMH levels are associated with a relevant risk of cycle cancellation but should not be considered a reason to exclude a couple from IVF.Keywords
This publication has 32 references indexed in Scilit:
- Probability of live birth in women with extremely low anti-Müllerian hormone concentrationsReproductive BioMedicine Online, 2014
- Ongoing Pregnancy Rates in Women with Low and Extremely Low AMH Levels. A Multivariate Analysis of 769 CyclesPLOS ONE, 2013
- Determining an anti-mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserveJournal of Assisted Reproduction and Genetics, 2013
- Pregnancy prognosis in women with anti-Müllerian hormone below the tenth percentileGynecological Endocrinology, 2013
- Different ovarian response by age in an anti-Müllerian hormone-matched group undergoing in vitro fertilizationJournal of Assisted Reproduction and Genetics, 2011
- The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive ageReproductive Biology and Endocrinology, 2011
- What is the role of assisted reproduction technology in the management of age-related infertility?Human Fertility, 2011
- Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserveFertility and Sterility, 2010
- Negligible serum anti-müllerian hormone: pregnancy and birth after a 1-month course of an oral contraceptive, ovarian hyperstimulation, and intracytoplasmic sperm injectionFertility and Sterility, 2009
- Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technologyHuman Reproduction, 2006